What Happened?
Cambridge, MA-based Catabasis-Pharmaceuticals Appointed Jill Milne as Founder
About the Company
At Catabasis Pharmaceuticals, our mission is to bring hope and life-changing therapies to patients and their families. Our SMART (Safely Metabolized And Rationally Targeted) Linker drug discovery platform enables us to engineer molecules that simultaneously modulate multiple targets in a disease. We are applying our SMART LinkerSM platform to build an internal pipeline of product candidates for rare diseases and plan to pursue partnerships to develop additional product candidates.
About the Person
Jill Milne is Founder at Catabasis Pharmaceuticals. Previously, Jill held various senior HR leadership roles in the industry.
Info Source
News
Short Profile